TAGX-0003

N/A

Report date: 2026/01/23 20:01:08
NME

Base Information

Drug NameTAGX-0003
Drug Alias Nameanti-IFNg38pManti-Interferon gamma DNA aptamer (Tagcyx Biotechnologies)anti-Interferon gamma DNA aptamer (Tagcyx Biotechnologies)TAGX-0003CGB-600
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide aptamer
Mechanisms of ActionInterferon gamma inhibitors
TargetsInterferon gamma
Therapy Area/IndicationsAutoimmune DiseasesVitiligoAlopecia Areata +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTagCyx Biotechnologies
China Registration ClassN/A

Develop Information

Active CompaniesTagCyx BiotechnologiesCAGE Bio Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesVitiligoAlopecia Areata +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A